Fundraising FoxArterius Ltd
1 known investors
Find your way into Arterius Ltd
Sign up to see every warm intro you have to Arterius Ltd
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Arterius Ltd team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Arterius develops next-generation, patient-centric medical devices, currently focused on treatments for peripheral arterial disease. The company has created two advanced polymer platforms used in devices to manage arterial disease without leaving long-term implants in the body.
Investors · 1
Companies House · registry record
View on Companies House ↗Has charges registered
- Registered name
- ARTERIUS LIMITED
- Company number
- 06981739
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 5 Aug 2009
- Registered office
- Mayesbrook House Lawnswood Business Park, Redvers Close, Leeds, West Yorkshire, LS16 6QY
- Nature of business (SIC)
- 72190 — Other research and experimental development on natural sciences and engineering
- Accounts
- last made up to 31 Mar 2025 · next due 31 Dec 2026
- Confirmation statement
- last made up to 30 Jan 2026 · next due 13 Feb 2027
Current officers · 6
- Kadem Al-Lamee — director, appointed 5 Aug 2009
- Barry Clare — director, appointed 28 Jan 2021
- Gerard David Harper — director, appointed 13 Mar 2023
- Peter James Mason — director, appointed 24 Mar 2015
- Ludvik Uhan — director, appointed 4 Jul 2018
- Deepbridge Ned Limited — corporate director, appointed 14 Feb 2024
Source: Companies House public register · retrieved 4 Oct 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Arterius Ltd do?
- Arterius develops next-generation, patient-centric medical devices, currently focused on treatments for peripheral arterial disease. The company has created two advanced polymer platforms used in devices to manage arterial disease without leaving long-term implants in the body.
- Who are Arterius Ltd's investors?
- Arterius Ltd's investors include Deepbridge Capital.